Literature DB >> 21133923

Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemia.

Kudret Tureyen1, Kellie Bowen, Jin Liang, Robert J Dempsey, Raghu Vemuganti.   

Abstract

One of the limiting factors in stroke therapeutic development is the use of animal models that do not well represent the underlying medical conditions of patients. In humans, diabetes increases the risk of stroke incidence as well as post-stroke mortality. To understand the mechanisms that render diabetics to increased brain damage, we evaluated the effect of transient middle cerebral artery occlusion in adult db/db mice. The db/db mouse is a model of type-2 diabetes with four times higher blood sugar than its normoglycemic genetic control(db/+ mouse). Following transient middle cerebral artery occlusion, the db/db mice showed significantly higher mortality, bigger infarcts, increased cerebral edema, worsened neurological status compared to db/+ mice. The db/db mice also showed significantly higher post-ischemic inflammatory markers (ICAM1(+) capillaries, extravasated macrophages/neutrophils and exacerbated proinflammatory gene expression) compared to db/+ mice. In addition, the post-ischemic neuroprotective heat-shock chaperone gene expression was curtailed in the db/db compared to db/+ mice.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21133923      PMCID: PMC3076322          DOI: 10.1111/j.1471-4159.2010.07127.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

1.  Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death.

Authors:  P Mehlen; C Kretz-Remy; X Préville; A P Arrigo
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

2.  Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia.

Authors:  S Sundararajan; J L Gamboa; N A Victor; E W Wanderi; W D Lust; G E Landreth
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

3.  Decreased brain damage and curtailed inflammation in transcription factor CCAAT/enhancer binding protein beta knockout mice following transient focal cerebral ischemia.

Authors:  Ramya Kapadia; Kudret Tureyen; Kellie K Bowen; Haviryaji Kalluri; Peter F Johnson; Raghu Vemuganti
Journal:  J Neurochem       Date:  2006-08-08       Impact factor: 5.372

Review 4.  Axonal transport of choline acetyltransferase and 6-phosphofructokinase activities in genetically diabetic mice.

Authors:  N A Calcutt; G B Willars; D R Tomlinson
Journal:  Muscle Nerve       Date:  1988-12       Impact factor: 3.217

5.  Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats.

Authors:  Yi Zhao; Andreas Patzer; Thomas Herdegen; Peter Gohlke; Juraj Culman
Journal:  FASEB J       Date:  2006-06       Impact factor: 5.191

6.  Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice.

Authors:  R S Clements; W G Robison; M P Cohen
Journal:  J Diabetes Complications       Date:  1998 Jan-Feb       Impact factor: 2.852

7.  Effect of hyperthermia on glutamate release in ischemic penumbra after middle cerebral artery occlusion in rats.

Authors:  K Takagi; M D Ginsberg; M Y Globus; E Martinez; R Busto
Journal:  Am J Physiol       Date:  1994-11

8.  Reversible middle cerebral artery occlusion without craniectomy in rats.

Authors:  E Z Longa; P R Weinstein; S Carlson; R Cummins
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

9.  Abnormal splicing of the leptin receptor in diabetic mice.

Authors:  G H Lee; R Proenca; J M Montez; K M Carroll; J G Darvishzadeh; J I Lee; J M Friedman
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

10.  Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice.

Authors:  H Chen; O Charlat; L A Tartaglia; E A Woolf; X Weng; S J Ellis; N D Lakey; J Culpepper; K J Moore; R E Breitbart; G M Duyk; R I Tepper; J P Morgenstern
Journal:  Cell       Date:  1996-02-09       Impact factor: 41.582

View more
  45 in total

Review 1.  What Do Experimental Models Teach Us About Comorbidities in Stroke?

Authors:  Sunghee Cho; Jiwon Yang
Journal:  Stroke       Date:  2018-01-08       Impact factor: 7.914

2.  Exacerbated brain edema in a rat streptozotocin model of hyperglycemic ischemic stroke: Evidence for involvement of blood-brain barrier Na-K-Cl cotransport and Na/H exchange.

Authors:  Natalie Y Yuen; Olga V Chechneva; Yi-Je Chen; Yi-Chen Tsai; Logan K Little; James Dang; Daniel J Tancredi; Jacob Conston; Steven E Anderson; Martha E O'Donnell
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-09       Impact factor: 6.200

3.  Endocrine Regulator rFGF21 (Recombinant Human Fibroblast Growth Factor 21) Improves Neurological Outcomes Following Focal Ischemic Stroke of Type 2 Diabetes Mellitus Male Mice.

Authors:  Yinghua Jiang; Ning Liu; Qingzhi Wang; Zhanyang Yu; Li Lin; Jing Yuan; Shuzhen Guo; Bum Ju Ahn; Xiao-Jie Wang; Xiaokun Li; Eng H Lo; Xiaochuan Sun; Xiaoying Wang
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

Review 4.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 5.  Hyperglycemia, acute ischemic stroke, and thrombolytic therapy.

Authors:  Sherif Hafez; Maha Coucha; Askiel Bruno; Susan C Fagan; Adviye Ergul
Journal:  Transl Stroke Res       Date:  2014-03-13       Impact factor: 6.829

Review 6.  Diabetic aggravation of stroke and animal models.

Authors:  Ashish K Rehni; Allen Liu; Miguel A Perez-Pinzon; Kunjan R Dave
Journal:  Exp Neurol       Date:  2017-03-06       Impact factor: 5.330

7.  Energy restriction negates NMDA receptor antagonist efficacy in ischemic stroke.

Authors:  Jeong Seon Yoon; Mohamed R Mughal; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2011-06-10       Impact factor: 3.843

Review 8.  Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.

Authors:  Anne-Claire Dorsemans; David Couret; Anaïs Hoarau; Olivier Meilhac; Christian Lefebvre d'Hellencourt; Nicolas Diotel
Journal:  Neurogenesis (Austin)       Date:  2017-01-31

9.  Glucagon-Like Peptide-1 Strengthens the Barrier Integrity in Primary Cultures of Rat Brain Endothelial Cells Under Basal and Hyperglycemia Conditions.

Authors:  Shuji Fukuda; Shinsuke Nakagawa; Rie Tatsumi; Yoichi Morofuji; Tomonori Takeshita; Kentaro Hayashi; Kunihiko Tanaka; Takayuki Matsuo; Masami Niwa
Journal:  J Mol Neurosci       Date:  2015-12-11       Impact factor: 3.444

Review 10.  The immune system in stroke: clinical challenges and their translation to experimental research.

Authors:  Craig J Smith; Catherine B Lawrence; Beatriz Rodriguez-Grande; Krisztina J Kovacs; Jesus M Pradillo; Adam Denes
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.